— Know what they know.
Not Investment Advice

EMGE OTC

Emergent Health Corp
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -0.0% 1Y: +0.0% 3Y: -88.2% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $4193 mcap · Short 84% of daily vol

Cash Flow Trends

Operating Cash Flow
-$1M +35.7% ▲
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$1M +37.3% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$12K +104.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$67K-$79K-$289K-$2M-$2M
Depreciation & Amort.$10K$20K$108K$20K$20K
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$4K$5K$21K$191K$68K
Other Non-Cash Items-$1K-$3K-$1K$0$320K
Operating Cash Flow-$54K-$57K-$162K-$2M-$1M
— Investing Activities —
Capital Expenditures$0$0$0-$50K$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0-$584K$160K
Investing Cash Flow$0$0$0-$634K$160K
— Financing Activities —
Net Debt Issuance$0$0$250K$1M$821K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow$90K$0$250K$2M$1M
Net Change in Cash-$588K$169K$31K-$245K$12K
Cash End of Period$227K$169K$258K$13K$25K
Free Cash Flow-$54K-$57K-$162K-$2M-$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms